 |
| CLICK HERE TO VIEW CURRENT ISSUE |
 |
| Best of NAMA 2026 |
|
 |
|
HEARING DATE SET TO DETERMINE NEXT ROUND OF LITIGANTS IN GLYPHOSATE LAWSUIT
Jul. 1, 2020
Agri-Pulse reports:
A federal judge has set a hearing for July 23 on the question of whether to approve a class of potential future Roundup litigants, a controversial element of the $10 billion-plus settlement that Bayer announced last week.
The proposed class would include people who have been exposed to Roundup but may or may not have been diagnosed with non-Hodgkin lymphoma. One of the purposes of the $1.25 billion set aside for the class would be to provide diagnoses for the class members. Attorney fees are set at $150 million.
Attorneys for the potential class argued in a court filing last week that "the tragic reality" is that many of the individuals in the proposed class "are agricultural workers living in rural areas who may have limited or no English skills and are less likely to even be aware of the Roundup controversy."
A science panel chosen by the parties would be set up to answer the question of whether there is a causal connection between Roundup and NHL. If such a connection isn't established, the class members will be barred from claiming otherwise in any future lawsuits against Bayer, the company says.
|
|
|
|
|
